Clinical Trial Update: Safety and Immunogenicity Study of Na-GST-1 With or Without CpG [Phase 1]

View source ↗

Summary

Phase 1 safety and immunogenicity study of the Na-GST-1 hookworm vaccine with or without CpG adjuvant completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hookworm Disease
• Hookworm Infection

Drugs mentioned

• CpG adjuvant (CpG oligodeoxynucleotide)
• Na-GST-1 vaccine (Na-GST-1)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Hookworm Infection, Hookworm Disease | Phase 1 | Status: COMPLETED | Results posted: 2025-07-04